Related Experiment Video
Updated: Aug 3, 2025

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
Acute Kidney Injury because of Implanted Tobramycin Pellets: A Case Report
Josefine Windfeld-Mathiasen1, Henrik Horwitz1,2, Frederik Schwartz3
1Department of Clinical Pharmacology, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
Case:
A 50-year-old healthy man with normal kidney function underwent surgery for fracture-related infection. Unfortunately, the patient received 2.5 times the intended dose of tobramycin pellets in the medullary cavity and developed acute kidney failure. Given the intraosseous administration of tobramycin, the drug displayed an absorption-dependent pharmacokinetics and multiple treatments with hemodialysis were needed. However, the patient had a complete recovery, and the kidney function remained normal at the 2-year follow-up.
Conclusion:
Tobramycin pellets are nephrotoxic in supratherapeutic doses; however, it was reversible in this case. Owing to the intraosseous administration, multiple treatments with hemodialysis were required.
Insights
A patient experienced acute kidney failure after a supratherapeutic dose of tobramycin pellets but fully recovered after hemodialysis. This case highlights the reversible nephrotoxicity of tobramycin, even at high doses.
Area of Science:
- Nephrology
- Pharmacokinetics
- Bone Infections
Background:
- Fracture-related infections require targeted antibiotic treatment.
- Intraosseous administration of antibiotics can be effective for localized infections.
- Tobramycin is an aminoglycoside antibiotic with known nephrotoxic potential.
Observation:
- A 50-year-old male received 2.5 times the intended dose of tobramycin pellets during surgery for fracture-related infection.
- The patient developed acute kidney failure secondary to the supratherapeutic tobramycin dose.
- Intraosseous administration led to absorption-dependent pharmacokinetics and required multiple hemodialysis treatments.
Findings:
- Supratherapeutic doses of tobramycin pellets can cause significant nephrotoxicity.
- Despite the high dose and acute kidney injury, the nephrotoxicity was reversible.
- Hemodialysis was effective in managing tobramycin toxicity in this context.
Implications:
- This case demonstrates the potential for reversible kidney damage from high-dose intraosseous tobramycin.
- It underscores the importance of careful dosing and monitoring for aminoglycoside antibiotics, even with localized delivery.
- Recovery of renal function suggests that timely and aggressive supportive care, including hemodialysis, can mitigate severe outcomes.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care

